Doravirine is an HIV-1 non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral medications to treat HIV-1 infection. It works by decreasing the amount of HIV in the blood, helping to manage infection in adults and children, and is often used for its favorable lipid profile, low side effects, and effectiveness against certain drug-resistant virus strains. It is grouped under the following drug class(es): Reverse Transcriptase Inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pifeltro, Doravirina and Doravirinum. Its PubChem CID is 58460047.
Doravirine
| CAS No | 1338225-97-0 |
|---|---|
| Molecular Formula | C17H11ClF3N5O3 |
| Molecular Weight | 425.7 g/mol |
| Synonyms | 3-chloro-5-[[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Doravirine is an HIV-1 non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral medications to treat HIV-1 infection.
The listed CAS number is 1338225-97-0.
The listed molecular formula is C17H11ClF3N5O3.
The listed molecular weight is 425.7 g/mol.
3-chloro-5-[[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile.
The source lists Pifeltro, Doravirina and Doravirinum.